Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to compare the Clareon/Clareon Toric Intraocular Lenses (IOLs) to the Eyhance/Eyhance Toric IOLs in binocular Best Corrected Distance Visual Acuity (BCDVA) at 3 months postoperative.
This study will enroll adults 22 years of age and older diagnosed with cataracts in both eyes with planned bilateral cataract removal by routine small incision phacoemulsification surgery. Subjects will attend up to 7 scheduled visits: A screening visit, two operative visits, and four post-operative visits. The expected individual duration of participation in the study is 3 months.
Age
22 - No limit years
Sex
ALL
Healthy Volunteers
No
Seeta Eye Centers
Poughkeepsie, New York, United States
Cleveland Eye Clinic
Brecksville, Ohio, United States
Carolina Eyecare Physicians, LLC
Mt. Pleasant, South Carolina, United States
Vision for Life
Nashville, Tennessee, United States
Houston Eye Associates
Houston, Texas, United States
Berkeley Eye Center
Houston, Texas, United States
Texas Eye Research Center
Hurst, Texas, United States
The Eye Institute of Utah
Salt Lake City, Utah, United States
Start Date
October 10, 2022
Primary Completion Date
October 16, 2023
Completion Date
October 16, 2023
Last Updated
October 30, 2024
203
ACTUAL participants
Clareon IOL
DEVICE
Clareon Toric IOL
DEVICE
Eyhance IOL
DEVICE
Eyhance Toric IOL
DEVICE
Phacoemulsification surgery
PROCEDURE
Lead Sponsor
Alcon Research
NCT06979752
NCT07362043
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06060041